Low-Dose Colchicine Approved for CVD: Now What? - Medscape The recent US approval of a new low dose of colchicine 0 5 mg (Lodoco; Agepha Pharma) with a broad indication for use in atherosclerotic cardiovascular disease (ASCVD) represents a completely new
Risk-Calculator Flaws Not Explained by Statin Use - Medscape In an attempt to understand why the WHS cohort had a lower 10-year risk of ASCVD than that using the ACC AHA risk calculator, researchers asked whether patients starting statins or undergoing
Two-Step Screening Uncovers Heart Failure Risk in Diabetes A second screening step can effectively and efficiently identify adults with diabetes at high risk for heart failure, even for those deemed low risk by clinical risk assessment alone
Good Performance for Universal CVD Risk Prediction Model A universal cardiovascular disease (CVD) prediction tool performs well in patients with and without atherosclerotic CVD (ASCVD), a new study showed, suggesting this model could facilitate